The mutation frequencies of p53 exons 2–11 were 28.6%–55.6% in skin cancer patients with Bowen’s disease, basal cell carcinoma, or squamous cell carcinoma, again from the Black Foot disease area in Taiwan (Hsu et al. 1998). This evidence concerns the gene TP53 and basal cell carcinoma.